121 related articles for article (PubMed ID: 32593600)
1. Usefulness of intravitreal dexamethasone implant in the management of «Vogt-Koyanagi-Harada-like syndrome» secondary to map kinase pathway inhibition.
Campos Polo R; García Guisado D; Rubio Sánchez C; Márquez Ivacevich NT
Arch Soc Esp Oftalmol (Engl Ed); 2020 Oct; 95(10):501-506. PubMed ID: 32593600
[TBL] [Abstract][Full Text] [Related]
2. A case of Vogt-Koyanagi-Harada-like uveitis secondary to dabrafenib/trametinib therapy for advanced melanoma.
Brambati M; Giuffrè C; Marchese A; Bandello F; Modorati GM; Miserocchi E
Eur J Ophthalmol; 2022 Jan; 32(1):NP109-NP113. PubMed ID: 32998540
[TBL] [Abstract][Full Text] [Related]
3. Multimodal Imaging Approach in a Patient with Vogt-Koyanagi-Harada-like Syndrome Due to Dabrafenib and Trametinib Use for Cutaneous Melanoma.
Bellanca RF; Pinna A; Catania G; Belcastro E; Angi M; D'Amico Ricci G
Ocul Immunol Inflamm; 2023 Feb; 31(2):402-406. PubMed ID: 35113757
[TBL] [Abstract][Full Text] [Related]
4. Bilateral drug (ipilimumab)-induced vitritis, choroiditis, and serous retinal detachments suggestive of vogt-koyanagi-harada syndrome.
Wong RK; Lee JK; Huang JJ
Retin Cases Brief Rep; 2012; 6(4):423-6. PubMed ID: 25389947
[TBL] [Abstract][Full Text] [Related]
5. Case with metastatic cutaneous malignant melanoma that developed Vogt-Koyanagi-Harada-like uveitis following pembrolizumab treatment.
Enomoto H; Kato K; Sugawara A; Itabashi M; Kondo M
Doc Ophthalmol; 2021 Jun; 142(3):353-360. PubMed ID: 33392895
[TBL] [Abstract][Full Text] [Related]
6. Bilateral retinal pigment epithelium tears in acute Vogt-Koyanagi-Harada disease.
Mili-Boussen I; Letaief I; Dridi H; Ouertani A
Retin Cases Brief Rep; 2013; 7(4):350-4. PubMed ID: 25383819
[TBL] [Abstract][Full Text] [Related]
7. VOGT-KOYANAGI-HARADA DISEASE-LIKE UVEITIS IN A PATIENT WITH ADVANCED MELANOMA TREATED BY SEQUENTIAL ADMINISTRATION OF NIVOLUMAB AND DABRAFENIB/TRAMETINIB THERAPY.
Madoe A; Schauwvlieghe PP; Jacob J
Retin Cases Brief Rep; 2023 Sep; 17(5):611-615. PubMed ID: 37643052
[TBL] [Abstract][Full Text] [Related]
8. Treatment of persistent serous retinal detachment in Vogt-Koyanagi-Harada syndrome with intravitreal bevacizumab during the systemic steroid treatment.
Reibaldi M; Russo A; Avitabile T; Uva MG; Franco L; Longo A; Toro MD; Cennamo G; Mariotti C; Neri P; Noci ND; Russo V
Retina; 2014 Mar; 34(3):490-6. PubMed ID: 23903795
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome.
Karacorlu M; Arf Karacorlu S; Ozdemir H
Eur J Ophthalmol; 2006; 16(3):481-3. PubMed ID: 16761256
[TBL] [Abstract][Full Text] [Related]
10. Development of Acute Vogt-Koyanagi-Harada-like Syndrome during the Treatment Course with Vemurafenib for Metastatic Melanoma.
Apivatthakakul A; Kunavisarut P; Rothova A; Pathanapitoon K
Ocul Immunol Inflamm; 2020 Apr; 28(3):505-508. PubMed ID: 31161956
[No Abstract] [Full Text] [Related]
11. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
[TBL] [Abstract][Full Text] [Related]
12. The place of dexamethasone implant in patients with Vogt-Koyanagi-Harada disease who experienced systemic treatment-related hepatic dysfunction: A case series.
Ataş F; Kayabaşı M; Saatci AO
Taiwan J Ophthalmol; 2023; 13(4):543-547. PubMed ID: 38249494
[TBL] [Abstract][Full Text] [Related]
13. Vogt-Kayanagi-Harada-Like Uveitis Induced by Dabrafenib/Trametinib Therapy for Cutaneous Malignant Melanoma.
Kaymak NZ; Kaplan AT
Ophthalmic Surg Lasers Imaging Retina; 2023 Aug; 54(8):477-480. PubMed ID: 37535619
[TBL] [Abstract][Full Text] [Related]
14. Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma.
Obata S; Saishin Y; Teramura K; Ohji M
Case Rep Ophthalmol; 2019; 10(1):67-74. PubMed ID: 31097947
[TBL] [Abstract][Full Text] [Related]
15. Uveitis and serous retinal detachment secondary to systemic dabrafenib and trametinib.
Rueda-Rueda T; Sánchez-Vicente JL; Moruno-Rodríguez A; Molina-Socola FE; Martínez-Borrego AC; López-Herrero F
Arch Soc Esp Oftalmol (Engl Ed); 2018 Sep; 93(9):458-462. PubMed ID: 29580759
[TBL] [Abstract][Full Text] [Related]
16. Vogt Koyanagi Harada syndrome in a 15-year-old girl, steroids side effects and recurrences.
Yıldırım G; Çavdarlı C; Özdemir EY; Alp MN
Turk J Pediatr; 2021; 63(3):527-532. PubMed ID: 34254501
[TBL] [Abstract][Full Text] [Related]
17. HLA-DRB1*04:05 in two cases of Vogt-Koyanagi-Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapy.
Fujimura T; Kambayashi Y; Tanita K; Sato Y; Hidaka T; Otsuka A; Tanaka H; Furudate S; Hashimoto A; Aiba S
J Dermatol; 2018 Jun; 45(6):735-737. PubMed ID: 29488243
[TBL] [Abstract][Full Text] [Related]
18. Unusual Case of Vogt-Koyanagi-Harada Disease Associated with SAPHO Syndrome: A Case Report.
Hasegawa M; Fukutomi A; Jinno A; Fujita K; Kamei M
Case Rep Ophthalmol; 2018; 9(1):202-208. PubMed ID: 29681837
[TBL] [Abstract][Full Text] [Related]
19. Ocular syphilis mimicking Vogt-Koyanagi-Harada disease.
Lin YC; Lo KJ; Chen SJ; Hwang DK
Taiwan J Ophthalmol; 2019; 9(4):271-275. PubMed ID: 31942434
[TBL] [Abstract][Full Text] [Related]
20. Severe bilateral panuveitis during melanoma treatment by Dabrafenib and Trametinib.
Draganova D; Kerger J; Caspers L; Willermain F
J Ophthalmic Inflamm Infect; 2015; 5():17. PubMed ID: 26078801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
